Insiders
The Investor that Never Loses (PBY, LANC, SHLM)
Barington Capital is an activist hedge fund that has never had a bad investment, according to Dealbreaker magazine. The firm recently filed its Schedule 13F-HR filing with the SEC detailing its current holdings. Unfortunately, Barington has been holding many of its stocks for a long time which means that it may be too late for […]
Popularity: 23% [?]
19Feb2008 | Justin Kuepper | 0 comments | Continued
A Look Into Carl Icahn’s Portfolio
Institutional investors are required to disclose their significant holdings to the Securities and Exchange Commission through a Form 13F filing. One investor that filed today was billionaire activist investor Carl Icahn and his fund Icahn Capital LP’s activity for the period ended December 31, 2007. Although the investor has experienced issues with some of his […]
Popularity: 22% [?]
14Feb2008 | Justin Kuepper | 0 comments | Continued
An Insider’s Prospective on Yahoo (YHOO)
Yahoo Inc.’s (NDAQ: YHOO) Jerry Yang lays out a very compelling argument for why he rejected the Yahoo bid in a letter to employees that we obtained through an 8-K filing with the SEC.
Here’s a transcript of the e-mail (exhibit 99.1):
Subject: our board’s decision
as you’ll see from the news release we issued today, our board […]
Popularity: 25% [?]
12Feb2008 | Justin Kuepper | 0 comments | Continued
Many Bank on E*Trade Turnaround (ETFC)
E*Trade Financial Corporation (NYSE: ETFC) shares rose today after insiders revealed a sharp increase in their holdings of the troubled online brokerage. The stock is more than 80% off of its highs primarily as a result of its subprime exposure, which led to speculation that it may be forced to shut its doors. In reality, […]
Popularity: 26% [?]
6Feb2008 | Justin Kuepper | 0 comments | Continued
BioSante’s LibiGel Has Insiders Buying (BPAX)
BioSante Pharmaceuticals, Inc. (NDAQ: BPAX) insiders appeal to be bullish on the stock as it approaches its 52-week low. The biopharmaceutical company, which is developing a female sexual dysfunction drug, saw executives and directors purchase some 151,000 shares in just the last month between $3.59 and $3.98. Meanwhile, not a single insider has sold stock […]
Popularity: 24% [?]
16Jan2008 | Justin Kuepper | 0 comments | Continued
During the great bull market of the '80's-90's, $1,000 invested in Franklin Resources became $1,000,000 during a period of about ...
Ben Stein, the financial writer (and actor), wrote a landmark analysis of Peltz's rise in 1989. Asked recently what he ...
Wow - finally someone speaks the truth about the accounting deceptions employed by insurers and the big banks. Imagine paying ...
I found your site on technorati and read a few of your other posts. Keep up the good work. ...